Leap Therapeutics, Inc. (LPTX)
NASDAQ: LPTX · IEX Real-Time Price · USD
3.290
+0.090 (2.81%)
At close: Apr 24, 2024, 4:00 PM
3.220
-0.070 (-2.13%)
After-hours: Apr 24, 2024, 4:59 PM EDT

Leap Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013
Revenue
001.51.5000000
Upgrade
Gross Profit
001.51.5000000
Upgrade
Selling, General & Admin
13.8111.810.779.629.098.929.854.011.515.37
Upgrade
Research & Development
73.2344.9732.1620.4224.3721.8322.523.2910.4115.54
Upgrade
Operating Expenses
87.0456.7642.9330.0433.4530.7532.3527.311.9220.92
Upgrade
Operating Income
-87.04-56.76-41.43-28.54-33.45-30.75-32.35-27.3-11.92-20.92
Upgrade
Interest Expense / Income
00.050.040.040.020.020.651.230.134.54
Upgrade
Other Expense / Income
-5.63-2.37-0.86-1.06-0.57-7.65-3.12-2.91-0-0.04
Upgrade
Pretax Income
-81.41-54.45-40.61-27.52-32.9-23.12-29.88-25.63-12.05-25.42
Upgrade
Income Tax
00.15-0.02-0-00.02-0.16000.03
Upgrade
Net Income
-81.41-54.6-40.59-27.51-32.9-23.14-29.73-25.63-12.05-25.45
Upgrade
Preferred Dividends
00010.070.3600.24000
Upgrade
Net Income Common
-81.41-54.6-40.59-37.59-33.26-23.14-29.97-25.63-12.05-25.45
Upgrade
Shares Outstanding (Basic)
20119621111-
Upgrade
Shares Outstanding (Diluted)
201196211---
Upgrade
Shares Change
80.55%31.94%44.66%162.71%56.69%56.85%-2.17%---
Upgrade
EPS (Basic)
-3.98-4.82-4.70-6.30-14.70-16.40-32.70--11.60-21.50
Upgrade
EPS (Diluted)
-3.98-4.82-4.70-6.30-14.70-21.10-33.10--11.60-21.50
Upgrade
Free Cash Flow
-43.75-49.04-35.16-25.93-26.99-26.03-22.2-25.48-8.1-18.24
Upgrade
Free Cash Flow Per Share
-2.14-4.33-4.10-4.37-11.95-18.41-24.23-27.13-8.63-
Upgrade
Gross Margin
--100.00%100.00%------
Upgrade
Operating Margin
---2761.73%-1902.60%------
Upgrade
Profit Margin
---2705.80%-2505.87%------
Upgrade
Free Cash Flow Margin
---2343.80%-1728.80%------
Upgrade
EBITDA
-81.4-54.38-40.54-27.44-32.83-23.05-29.19-24.37-11.92-20.22
Upgrade
EBITDA Margin
---2702.73%-1829.53%------
Upgrade
Depreciation & Amortization
0.020.020.030.030.050.050.050.0300.66
Upgrade
EBIT
-81.41-54.4-40.57-27.48-32.88-23.1-29.24-24.4-11.92-20.88
Upgrade
EBIT Margin
---2704.67%-1831.80%------
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).